Emi M, Matsushima M, Katagiri T, Yoshimoto M, Kasumi F, Yokota T, Nakata T, Miki Y, Nakamura Y
Laboratory of Molecular Medicine, Institute of Medical Science, University of Tokyo.
Jpn J Cancer Res. 1998 Jan;89(1):12-6. doi: 10.1111/j.1349-7006.1998.tb00472.x.
To detect BRCA1 mutations in Japanese breast cancer patients, we screened 1,000 unselected primary cancers for mutations in exon 11, which accounts for 61% of the entire BRCA1 coding sequence. Using a method based on multiplex single-strand conformational polymorphism (SSCP) analysis of multiple restriction fragments generated by restriction-enzyme digestion of amplified DNA, we identified eight mutations. All eight were germline mutations; four of them were non-sense mutations or small deletions resulting in premature stop codons, and the other four were missense mutations. The Japanese carriers of these mutant BRCA1 alleles had developed breast cancers at ages ranging from 45 to 62, five of them bilaterally.
为检测日本乳腺癌患者中的BRCA1基因突变,我们对1000例未经选择的原发性癌症进行筛查,检测外显子11的突变,该外显子占整个BRCA1编码序列的61%。我们采用一种基于对扩增DNA经限制性酶切产生的多个限制性片段进行多重单链构象多态性(SSCP)分析的方法,鉴定出8个突变。所有8个均为种系突变;其中4个为无义突变或导致过早终止密码子的小缺失,另外4个为错义突变。这些携带突变BRCA1等位基因的日本人患乳腺癌的年龄在45至62岁之间,其中5例为双侧发病。